Catalyst Wire Dossier Catalyst Wire Dossier

Ursofalk

Ursodeoxycholic acid
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ursofalk, covering 2013-05-20 to 2019-05-07. Get the full timeline:

Most recent: Clinical Trial Update: Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis [Phase 4]

See pricing